These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

740 related items for PubMed ID: 29258482

  • 21. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
    Wu WF, Wang JN, Li Z, Wei B, Jin J, Gao L, Li HD, Li J, Chen HY, Meng XM.
    Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Monitoring treatment of acute kidney injury with damage biomarkers.
    Pianta TJ, Succar L, Davidson T, Buckley NA, Endre ZH.
    Toxicol Lett; 2017 Feb 15; 268():63-70. PubMed ID: 28065798
    [Abstract] [Full Text] [Related]

  • 25. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE.
    J Diabetes Complications; 2017 Dec 15; 31(12):1704-1709. PubMed ID: 29037450
    [Abstract] [Full Text] [Related]

  • 26. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.
    Yang C, Guo Y, Huang TS, Zhao J, Huang XJ, Tang HX, An N, Pan Q, Xu YZ, Liu HF.
    Biomed Pharmacother; 2018 Nov 15; 107():1354-1362. PubMed ID: 30257350
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2.
    Yang Y, Liu S, Gao H, Wang P, Zhang Y, Zhang A, Jia Z, Huang S.
    Free Radic Biol Med; 2020 May 20; 152():821-837. PubMed ID: 32004633
    [Abstract] [Full Text] [Related]

  • 32. Neutrophil gelatinase-associated lipocalin production negatively correlates with HK-2 cell impairment: Evaluation of NGAL as a marker of toxicity in HK-2 cells.
    Hauschke M, Roušarová E, Flídr P, Čapek J, Libra A, Roušar T.
    Toxicol In Vitro; 2017 Mar 20; 39():52-57. PubMed ID: 27888128
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impaired Tubular Reabsorption Is the Main Mechanism Explaining Increases in Urinary NGAL Excretion Following Acute Kidney Injury in Rats.
    Sancho-Martínez SM, Blanco-Gozalo V, Quiros Y, Prieto-García L, Montero-Gómez MJ, Docherty NG, Martínez-Salgado C, Morales AI, López-Novoa JM, López-Hernández FJ.
    Toxicol Sci; 2020 May 01; 175(1):75-86. PubMed ID: 32110797
    [Abstract] [Full Text] [Related]

  • 35. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition.
    Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C, Racusen L, Rabb H.
    Am J Physiol Renal Physiol; 2010 Jun 01; 298(6):F1472-83. PubMed ID: 20181666
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.
    Tanase DM, Gosav EM, Radu S, Costea CF, Ciocoiu M, Carauleanu A, Lacatusu CM, Maranduca MA, Floria M, Rezus C.
    Int J Mol Sci; 2019 Oct 22; 20(20):. PubMed ID: 31652595
    [Abstract] [Full Text] [Related]

  • 38. The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury.
    Pickering JW, Endre ZH.
    Blood Purif; 2013 Oct 22; 35(4):295-302. PubMed ID: 23712081
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.